Rural Health Academic Centre, Melbourne Medical School, The University of Melbourne, 'Dunvegan' 806 Mair St, Ballarat, Victoria 3350, Australia.
Crit Care. 2011;15(1):R7. doi: 10.1186/cc9406. Epub 2011 Jan 7.
Selective digestive decontamination (SDD) appears to have a more compelling evidence base than non-antimicrobial methods for the prevention of ventilator associated pneumonia (VAP). However, the striking variability in ventilator associated pneumonia-incidence proportion (VAP-IP) among the SDD studies remains unexplained and a postulated contextual effect remains untested for.
Nine reviews were used to source 45 observational (benchmark) groups and 137 component (control and intervention) groups of studies of SDD and studies of three non-antimicrobial methods of VAP prevention. The logit VAP-IP data were summarized by meta-analysis using random effects methods and the associated heterogeneity (tau2) was measured. As group level predictors of logit VAP-IP, the mode of VAP diagnosis, proportion of trauma admissions, the proportion receiving prolonged ventilation and the intervention method under study were examined in meta-regression models containing the benchmark groups together with either the control (models 1 to 3) or intervention (models 4 to 6) groups of the prevention studies.
The VAP-IP benchmark derived here is 22.1% (95% confidence interval; 95% CI; 19.2 to 25.5; tau2 0.34) whereas the mean VAP-IP of control groups from studies of SDD and of non-antimicrobial methods, is 35.7 (29.7 to 41.8; tau2 0.63) versus 20.4 (17.2 to 24.0; tau2 0.41), respectively (P < 0.001). The disparity between the benchmark groups and the control groups of the SDD studies, which was most apparent for the highest quality studies, could not be explained in the meta-regression models after adjusting for various group level factors. The mean VAP-IP (95% CI) of intervention groups is 16.0 (12.6 to 20.3; tau2 0.59) and 17.1 (14.2 to 20.3; tau2 0.35) for SDD studies versus studies of non-antimicrobial methods, respectively.
The VAP-IP among the intervention groups within the SDD evidence base is less variable and more similar to the benchmark than among the control groups. These paradoxical observations cannot readily be explained. The interpretation of the SDD evidence base cannot proceed without further consideration of this contextual effect.
选择性消化道去污染(SDD)似乎比非抗菌方法在预防呼吸机相关性肺炎(VAP)方面具有更有力的证据基础。然而,SDD 研究中呼吸机相关性肺炎发生率比例(VAP-IP)的显著差异仍然无法解释,并且假设的背景效应仍未得到检验。
使用 9 项综述来获取 SDD 研究和三种非抗菌性 VAP 预防方法的 45 个观察性(基准)组和 137 个(对照和干预)组的研究。使用随机效应方法对对数 VAP-IP 数据进行汇总,并测量相关异质性(tau2)。作为 VAP-IP 的组水平预测因子,在包含基准组的荟萃回归模型中,对 VAP 诊断方式、创伤入院比例、接受长时间通气的比例以及正在研究的干预方法进行了检查,同时还包含了预防研究的对照组(模型 1 至 3)或干预组(模型 4 至 6)。
这里得出的 VAP-IP 基准值为 22.1%(95%置信区间;95%CI;19.2 至 25.5;tau2 0.34),而 SDD 研究和非抗菌方法研究的对照组的平均 VAP-IP 分别为 35.7(29.7 至 41.8;tau2 0.63)和 20.4(17.2 至 24.0;tau2 0.41)(P < 0.001)。在 SDD 研究的基准组与对照组之间存在明显的差异,这在最高质量的研究中最为明显,即使在调整了各种组水平因素后,该差异也无法在荟萃回归模型中得到解释。干预组的平均 VAP-IP(95%CI)为 SDD 研究的 16.0(12.6 至 20.3;tau2 0.59)和 17.1(14.2 至 20.3;tau2 0.35),而非抗菌方法的研究分别为 16.0(12.6 至 20.3;tau2 0.59)和 17.1(14.2 至 20.3;tau2 0.35)。
在 SDD 证据基础中,干预组的 VAP-IP 比对照组的变异性更小,与基准值更相似。这些矛盾的观察结果难以解释。如果不进一步考虑这种背景效应,就无法对 SDD 证据基础进行解释。